Median duration of follow-up was 49.6 months and 49.4 months for patients randomized to semaglutide tablets and placebo, respectively
Lower tirzepatide doses (510mg weekly) reduce GI side effect burden while still providing meaningful appetite suppression, allowing researchers to maintain protocol adherence without the nausea and vomiting that causes 1015% of subjects to discontinue at higher doses
sEVs display superiority over other components, as they generally exist in biological liquids and can be easily isolated, stored, and transported
Semaglutide follows the generic (ANDA) pathway because it's a synthetic peptide, not a biologic
Both platforms work with insurance when possible, but many users pay out-of-pocket for speed and medication selection
After I told them it wasnt working, I got this unprofessional email telling me if I rejoined it would be $900 to join again